232 related articles for article (PubMed ID: 1283849)
21. Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.
Burris HA; Fields S
Semin Oncol; 1994 Oct; 21(5 Suppl 10):14-9; discussion 19-20. PubMed ID: 7973764
[TBL] [Abstract][Full Text] [Related]
22. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
23. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
Aapro MS
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
[TBL] [Abstract][Full Text] [Related]
24. Current position of vinorelbine in cancer chemotherapy.
Sørensen JB
Ann Oncol; 1995 Feb; 6(2):105-7. PubMed ID: 7786816
[No Abstract] [Full Text] [Related]
25. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
26. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
27. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
28. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer.
Jones SF; Burris HA
Ann Pharmacother; 1996 May; 30(5):501-6. PubMed ID: 8740332
[TBL] [Abstract][Full Text] [Related]
29. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
Vokes EE
Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
[TBL] [Abstract][Full Text] [Related]
30. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
31. Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude mice.
Kolberg HC; Villena-Heinsen C; Deml MM; Kraemer S; Diedrich K; Friedrich M
Eur J Gynaecol Oncol; 2005; 26(4):398-402. PubMed ID: 16122187
[TBL] [Abstract][Full Text] [Related]
32. Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.
Gralla RJ; Gatzemeier U; Gebbia V; Huber R; O'Brien M; Puozzo C
Drugs; 2007; 67(10):1403-10. PubMed ID: 17600389
[TBL] [Abstract][Full Text] [Related]
33. Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients.
Pace A; Bove L; Nisticò C; Ranuzzi M; Innocenti P; Pietrangeli A; Terzoli E; Jandolo B
J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):409-11. PubMed ID: 8890782
[TBL] [Abstract][Full Text] [Related]
34. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
35. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
[TBL] [Abstract][Full Text] [Related]
37. Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy.
O'Reilly S; Kennedy MJ; Rowinsky EK; Donehower RC
Breast Cancer Res Treat; 1995; 33(1):1-17. PubMed ID: 7749128
[TBL] [Abstract][Full Text] [Related]
38. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
Tirelli U; Balzarotti M; Uziel L; Ferreri AJ; Santoro A; Spina M
Ann Oncol; 2006 Mar; 17(3):533. PubMed ID: 16291585
[No Abstract] [Full Text] [Related]
39. Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma.
Carter CA; Chen C; Brink C; Vincent P; Maxuitenko YY; Gilbert KS; Waud WR; Zhang X
Cancer Chemother Pharmacol; 2007 Feb; 59(2):183-95. PubMed ID: 16724239
[TBL] [Abstract][Full Text] [Related]
40. Vinorelbine--a clinical review.
Gregory RK; Smith IE
Br J Cancer; 2000 Jun; 82(12):1907-13. PubMed ID: 10864196
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]